Conmed (CNMD) Net Margin (2010 - 2026)

Conmed's Net Margin history runs 17 years deep, the most recent figure standing at 4.36% for Q1 2026.

• Quarterly Net Margin rose 248.0% year-over-year to 4.36% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.33% (down 936.0% YoY) and the FY2025 annual result came in at 0.9%, down 1103.0% from the prior year.
• Net Margin was 4.36% for Q1 2026 at Conmed, up from 11.43% in the prior quarter.
• Across five years, Net Margin topped out at 37.99% in Q4 2022 and bottomed at 60.71% in Q2 2022.
• A 5-year average of 2.4% and a median of 5.2% in 2023 frame the typical range for Net Margin.
• Annual changes were most pronounced in 2022 — Net Margin plunged 6592 bps — and 2023, when it jumped 6504 bps.
• Conmed's Net Margin stood at 37.99% in 2022, then sank by 132 bps to 12.0% in 2023, then surged by 181 bps to 9.76% in 2024, then sank by 217 bps to 11.43% in 2025, then soared by 138 bps to 4.36% in 2026.
• Business Quant data shows CNMD's Net Margin at 4.36% in Q1 2026, 11.43% in Q4 2025, and 0.85% in Q3 2025.